Access cutting-edge kaposi sarcoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access kaposi sarcoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kaposi sarcoma treatment provided free
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Sponsor: AIDS Malignancy Consortium
Check if you qualify for this kaposi sarcoma clinical trial in New York, NY
If you're searching for kaposi sarcoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kaposi sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.